Details for New Drug Application (NDA): 087377
✉ Email this page to a colleague
NDA 087377 describes FLUTEX, which is a drug marketed by Ivax Pharms and is included in four NDAs. Additional details are available on the FLUTEX profile page.
The generic ingredient in FLUTEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in FLUTEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 087377
| Tradename: | FLUTEX |
| Applicant: | Ivax Pharms |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087377
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.1% | ||||
| Approval Date: | Nov 1, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
